Evaluation of organ-specific relative biological effectiveness of proton therapy using radiation-induced pneumonitis as an endpoint
This study demonstrated that the RBE of proton therapy for RP2+ is variable and higher than the conventional 1.1 assumption, emphasizing the need to account for variable RBE in treatment planning.
Authors
- Steven Jay Frank (ORCID: https://orcid.org/0000-0001-6517-7884)
- Li Liao (ORCID: https://orcid.org/0000-0002-6651-0033)
- Ting‐Shi Su (ORCID: https://orcid.org/0000-0003-3097-4394)
- N Sahoo
- Ting Xu (ORCID: https://orcid.org/0000-0002-7851-3389)
- Quynh‐Nhu Nguyen (ORCID: https://orcid.org/0000-0001-5274-6291)
- Xiaodong Zhang (ORCID: https://orcid.org/0000-0003-4654-2780)
- Mei Chen (ORCID: https://orcid.org/0009-0009-2838-7677)
- Xiaorong Zhu
- Zhongxing Liao
Institutions
- The University of Texas MD Anderson Cancer Center (US)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.ctro.2025.101089
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Texas MD Anderson Cancer Center